The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.
Source: [CNBC](https://www.cnbc.com/2026/08/19/moderna-merck-cancer-vaccine-shows-initial-late-stage-melanoma-data.html)